Stock Events

Stock Events

Talphera 

€0.7
0
+€0.04+5.69% Wednesday 06:02

Statistics

Day High
0.7
Day Low
0.7
52W High
1.22
52W Low
0.36
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18MayExpected
Q4 2025
Next
-0.06
-0.06
-0.06
-0.05
Expected EPS
-0.0594111
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow R5XA.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Talphera in the development and marketing of prescription medicines, vaccines, biologic therapies, and animal health products.
Pfizer
PFE
Mkt Cap153.13B
Pfizer Inc. is a global pharmaceutical corporation which competes directly with Talphera in various therapeutic areas, including oncology, rare diseases, and immunology.
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Talphera in the discovery, development, and delivery of innovative medicines that help patients prevail over serious diseases.
Gilead Sciences
GILD
Mkt Cap172.51B
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, competing with Talphera in the fields of antiviral drugs, cancer, and other diseases.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Talphera in areas such as immunology and oncology.
AMGEN
AMGN
Mkt Cap189.22B
Amgen Inc. is one of the world's leading biotechnology companies, competing with Talphera in developing innovative human therapeutics, including treatments for serious illnesses.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson is a comprehensive healthcare company that competes with Talphera through its pharmaceutical segment, developing drugs for a wide range of medical conditions.
Novartis
NVS
Mkt Cap297.35B
Novartis AG is a global healthcare company based in Switzerland that competes with Talphera in researching, developing, manufacturing, and marketing a broad range of healthcare products.
Roche
RHHBY
Mkt Cap322.3B
Roche Holding AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche competes with Talphera in the pharmaceutical sector, particularly in oncology and virology.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company that competes with Talphera in developing and commercializing prescription medicines for several therapeutic areas, including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

About

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.
Show more...
CEO
Mr. Vincent J. Angotti
Employees
13
Country
United States
ISIN
US00444T2096

Listings

STU
DE
R5XA.STU
MU
DE
R5XA.MU
XNAS
US
TLPH
F
DE
R5XA.F

0 Comments

Share your thoughts

FAQ

What is Talphera stock price today?▼
The current price of R5XA.MU is €0.7 EUR — it has increased by +5.69% in the past 24 hours. Watch Talphera stock price performance more closely on the chart.
What is Talphera stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Talphera stocks are traded under the ticker R5XA.MU.
Is Talphera stock price growing?▼
R5XA.MU stock has risen by +2.8% compared to the previous week, the month change is a -0.23% fall, over the last year Talphera has showed a +65.78% increase.
When is the next Talphera earnings date?▼
Talphera is going to release the next earnings report on May 18, 2026.
What were Talphera earnings last quarter?▼
R5XA.MU earnings for the last quarter are -0.05 EUR per share, whereas the estimation was -0.06 EUR resulting in a +20% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Talphera have?▼
As of April 17, 2026, the company has 13 employees.
In which sector is Talphera located?▼
Talphera operates in the Health & Wellness sector.
When did Talphera complete a stock split?▼
Talphera has not had any recent stock splits.
Where is Talphera headquartered?▼
Talphera is headquartered in San Mateo, United States.